Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to […]
Wiley
Wiley
Wiley
HLA‐DQA1*01:02 is associated with antibody multi‐reactivity with citrulline‐containing type II collagen epitopes while HLA‐DRB1*04:01 is associated with more private antibody reactivity with citrulline‐containing IgG epitopes in rheumatoid arthritis
Objective Anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) can be promiscuous, with cross-reactive binding to many antigens containing short
Wiley
Longitudinal Autoantibody and Proteomic Signatures of Disease Progression in Systemic Sclerosis
Objective To evaluate dynamic changes in autoantibody and proteomic profiles in treatment-naïve patients with systemic sclerosis (SSc) and to identify
Wiley
Pregnancy Outcomes in Women With Systemic Sclerosis Before and/or After Diagnosis and by Parity: A Swedish Population‐Based Cohort Study
Objective To assess risks of adverse pregnancy outcomes (APOs) in a contemporary cohort of women with systemic sclerosis (SSc) in
Wiley
The Inaugural NIH‐Wide Strategic Plan for Autoimmune Disease Research (FY2026–2030)
Arthritis &Rheumatology, Accepted Article.
Wiley
Deficiency of Cartilage‐Specific Y‐Box Binding Protein 1 Represses NF‐κB Signaling and Alleviates Osteoarthritis Progression
Objective The objective of our study was to explore the role of Y-box binding protein 1 (YBX1) in the pathogenesis
Wiley
Interleukin (IL)‐5, Eosinophils and IL‐5 Pathway Inhibitors in Eosinophilic Granulomatosis with Polyangiitis.
Arthritis &Rheumatology, Accepted Article.
Wiley
Making the Most of Advanced Computed Tomography Imaging Techniques for Medical Decision‐Making in Arthritis Imaging
Arthritis &Rheumatology, EarlyView.
Wiley
TIPIC syndrome induced by G‐CSF: comment on the article by Namineni et al
Arthritis &Rheumatology, EarlyView.
Wiley
When Less Is More, None Can Be Even Better: Rethinking Routine Follow‐Up of Chronic Disease Exemplified With Rheumatoid Arthritis
Arthritis &Rheumatology, EarlyView.
Wiley
Longitudinal Changes in Serum Urate Levels from Pre‐menopause through Post‐menopause: Interrupted Time‐Series Analyses
Objectives Hyperuricemia (HU) and gout are common in post-menopausal women. We aimed to identify the longitudinal changes in serum urate
Wiley
Is Serum Uric Acid a Mere Bystander or an Active Player in Osteoarthritis Pathogenesis?
Arthritis &Rheumatology, Accepted Article.
Wiley
Granulomatosis with polyangiitis presenting as strawberry gingivitis: methodologic aspects: comment on the article by Liu et al
Arthritis &Rheumatology, Volume 77, Issue 10, Page 1454-1454, October 2025.
Wiley
Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell‐Targeted Therapies
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients
Wiley
The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical Outcomes
Objective To evaluate the association of neighborhood deprivation and structural barriers with disease burden in racial and ethnic subsets of
Wiley
Old techniques still have relevance in personalised predictive medicine
Arthritis &Rheumatology, Accepted Article.
Wiley
Glucagon‐Like Peptide‐1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
Objective Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardioprotective and kidney-protective benefits among patients with type 2 diabetes (T2D). We sought
Wiley
EAT‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature
Objective To investigate the association between the EAT-Lancet diet and rheumatoid arthritis (RA) and the underlying metabolic mechanisms. Methods This
Wiley
Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders?
Arthritis &Rheumatology, EarlyView.
Wiley
Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis
Objective Placebo effects are a significant challenge in the conduct of clinical trials. We explored how global recruitment patterns influence
Wiley
A Polyamine Takes the Fast Track to Attack Crystal‐Induced Inflammation
Arthritis &Rheumatology, Accepted Article.
Wiley
Long‐term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL‐12/IL‐23 cytokines in PSTPIP1‐associated inflammatory diseases
Arthritis &Rheumatology, Accepted Article.
Wiley
Linking Skin and Joint Inflammation in Psoriatic Arthritis through Shared CD8+ T Cell Clones
Objective Psoriatic arthritis (PsA) is an HLA class I–associated inflammatory arthritis that develops in up to 30% of people with
Wiley
Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease
Objective Although up to 45% of patients with psoriatic arthritis (PsA) have a family history of psoriatic disease, it is
Wiley
Genetics of Childhood‐Onset Systemic Lupus Erythematosus
Objective Genome-wide association studies (GWAS) have identified >100 loci for systemic lupus erythematosus (SLE). These loci may also affect age
Wiley
Monocyte‐Derived Macrophages‐Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis
Objective Osteoarthritis (OA) is a debilitating joint disease that is characterized by cartilage degradation, synovial inflammation, and pain. Macrophages have